Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella species surface and virulence antigens are a complex array of molecules, including lipopolysaccharides (O antigens), flagellar proteins (H antigens), and capsular polysaccharides (Vi antigens), that mediate the bacteria's interaction with the host environment (StatPearls, 2023). These antigens are fundamental to the pathogenesis of salmonellosis and enteric fever, facilitating bacterial motility, adhesion to the intestinal mucosa, and invasion of host cells via specialized structures like the Type III Secretion System (T3SS) (PMID: 30249834). The Vi antigen, specifically found in Salmonella Typhi, plays a crucial role in masking the bacteria from the host's innate immune system, thereby promoting systemic infection (PMID: 28943528). Therapeutically, these antigens serve as the primary components of vaccines, such as the Vi capsular polysaccharide vaccine and the live-attenuated Ty21a vaccine, which elicit protective antibody and cellular immune responses (WHO, 2018). Furthermore, these surface structures are the basis for serological classification and diagnostic testing, making them indispensable for epidemiological surveillance and clinical management of Salmonella infections.
Induction of protective immune responses (active immunization) through the production of specific antibodies (e.g., anti-Vi IgG) that opsonize bacteria for phagocytosis or prevent bacterial attachment to host tissues (WHO, 2018). Experimental therapies may target virulence factors like the T3SS to inhibit the injection of effector proteins, thereby preventing host cell invasion (PMID: 30249834).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella species surface and virulence antigens (Salmonella antigens).